– Proceeds to Advance Breakthrough Drug Stabilization Technology Enabling Thermostable and Concentrated Formulation of Biologics –– Financing Co-Led by Breakout Ventures and the Perceptive Xontogeny Venture Fund –PALO ALTO, Calif. (BUSINESS WIRE) Surf Bio, Inc., a biopharmaceutical company commercializing a novel.
Newport Beach-based VivoSense, a company using wearable sensors for the clinical trials market, says it has raised $25M in a Series A funding round. The roudn came from Debiopharm and the Perceptive Xont